Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.
复制标题

DOI:
10.1016/j.ccell.2017.04.003
复制
发表时间:
2017-05-08
期刊:
影响因子:
50.3
通讯作者:
Gajewski TF
Gajewski TF
中科院分区:
医学1区
文献类型:
--
作者:
Spranger S;Dai D;Horton B;Gajewski TF

文献摘要

参考文献

被引文献

相似文献

效应T细胞具有识别和杀死癌细胞的能力。然而,肿瘤是否可以通过从肿瘤微环境中排除效应T细胞而变得免疫耐受尚不清楚。通过使用类似于非T细胞发炎的人类肿瘤的肿瘤模型,我们评估了过继性T细胞转移是否可以克服失败的自发引发。流式细胞术分析结合活体成像表明效应T细胞进入肿瘤的运输失败。从机制上讲,这是由于CXCL 9/10的缺乏,我们发现CXCL 9/10是由T细胞炎症肿瘤中的CD 103+树突状细胞(DC)产生的。我们的数据表明,肿瘤微环境中缺乏CD 103 + DC主要抵抗抗肿瘤T细胞反应的效应期,从而导致免疫逃逸。
Effector T cells have the capability of recognizing and killing cancer cells. However, whether tumors can become immune-resistant through exclusion of effector T cells from the tumor microenvironment is not known. By using a tumor model resembling non-T cell-inflamed human tumors, we assessed whether adoptive T cell transfer might overcome failed spontaneous priming. Flow cytometric assays combined with intra-vital imaging indicated failed trafficking of effector T cells into tumors. Mechanistically, this was due to absence of CXCL9/10, which we found to be produced by CD103+ dendritic cells (DC) in T cell-inflamed tumors. Our data indicate that lack of CD103+ DC within the tumor microenvironment dominantly resists the effector phase of an anti-tumor T cell response, contributing to immune escape.
DOI: 10.1084/jem.20101159
发表时间: 2011-09-26
期刊: The Journal of experimental medicine
影响因子: --
作者:
Fuertes MB;Kacha AK;Kline J;Woo SR;Kranz DM;Murphy KM;Gajewski TF
通讯作者: Gajewski TF
DOI: 10.1056/nejmoa1003466
发表时间: 2010-08-19
期刊: The New England journal of medicine
影响因子: --
作者:
Hodi FS;O'Day SJ;McDermott DF;Weber RW;Sosman JA;Haanen JB;Gonzalez R;Robert C;Schadendorf D;Hassel JC;Akerley W;van den Eertwegh AJ;Lutzky J;Lorigan P;Vaubel JM;Linette GP;Hogg D;Ottensmeier CH;Lebbé C;Peschel C;Quirt I;Clark JI;Wolchok JD;Weber JS;Tian J;Yellin MJ;Nichol GM;Hoos A;Urba WJ
通讯作者: Urba WJ
DOI: 10.1158/0008-5472.can-08-2281
发表时间: 2009-04-01
期刊: Cancer research
影响因子: 11.2
作者:
Harlin H;Meng Y;Peterson AC;Zha Y;Tretiakova M;Slingluff C;McKee M;Gajewski TF
通讯作者: Gajewski TF
DOI: 10.1016/j.immuni.2015.08.006
发表时间: 2015-09-15
期刊: Immunity
影响因子: 32.4
作者:
Joshi NS;Akama-Garren EH;Lu Y;Lee DY;Chang GP;Li A;DuPage M;Tammela T;Kerper NR;Farago AF;Robbins R;Crowley DM;Bronson RT;Jacks T
通讯作者: Jacks T
DOI: 10.1038/nature10755
发表时间: 2012-02-08
期刊: NATURE
影响因子: 64.8
作者:
Matsushita, Hirokazu;Vesely, Matthew D.;Koboldt, Daniel C.;Rickert, Charles G.;Uppaluri, Ravindra;Magrini, Vincent J.;Arthur, Cora D.;White, J. Michael;Chen, Yee-Shiuan;Shea, Lauren K.;Hundal, Jasreet;Wendl, Michael C.;Demeter, Ryan;Wylie, Todd;Allison, James P.;Smyth, Mark J.;Old, Lloyd J.;Mardis, Elaine R.;Schreiber, Robert D.
通讯作者: Schreiber, Robert D.